Skip to content

AcuCort AB Sustainability Reports

AcuCort AB is an innovative biotech company that develops and commercializes bio-dissolvable oral films. Its primary product is Zeqmelit, a fast-dissolving oral film containing dexamethasone used to treat severe allergic reactions and acute asthma.

Sector: Professional & technical services

Country: Sweden

Exchange: Nordic Growth Market

ISIN: SE0009695927

5 reports from 2021 to 2025